Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s)-2-(4-(((3s)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic Acid
2. Dx 9065
3. Dx 9065a
4. Dx-9065a
1. Dx-9065a
2. 155204-81-2
3. Qxqvepevi2
4. Dx-9065a Hcl Hydrate
5. 155204-81-2 (hcl, Hydrate)
6. X-9065a
7. Dx 9065a
8. (s)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-(((s)-1-(1-iminoethyl)pyrrolidin-3-yl)oxy)phenyl)propanoic Acid Hydrochloride Pentahydrate
9. Dx-9065 Hydrochloride Pentahydrate
10. Unii-qxqvepevi2
11. (s-(r*,r*))-7-(aminoiminomethyl)-alpha-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-2-naphthalenepropanoic Acid Monohydrochloride, Pentahydrate
12. Dtxsid60935162
13. (2s)-2-(4-(((3s)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic Acid
14. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-alpha-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (s-(r*,r*))-
15. (+)-(2s)-2-[4-[[(3s)-1-acetimidoyl-3-pyrrolidi-nyl]oxy]phenyl]-3-[7-amidino-2-naphthyl] Propanoic Acid Hydrochloride Pentahydrate
16. (.alpha.s)-7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-2-naphthalenepropanoic Acid Hydrochloride Hydrate (1:1:5)
17. (2s)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-[(3s)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic Acid;pentahydrate;hydrochloride
18. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Hydrochloride, Hydrate (1:1:5), (.alpha.s)-
19. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-(((3s)-1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (.alpha.s)-
20. 2-naphthalenepropanoic Acid, 7-(aminoiminomethyl)-.alpha.-(4-((1-(1-iminoethyl)-3-pyrrolidinyl)oxy)phenyl)-, Monohydrochloride, Pentahydrate, (s-(r*,r*))-
21. 2-naphthalenepropanoic Acid,7-(aminoiminomethyl)-a-[4-[[(3s)-1-(1-iminoethyl)-3-pyrrolidinyl]oxy]phenyl]-,hydrochloride,hydrate (1:1:5),(as)-
22. 3-(7-carbamimidoylnaphthalen-2-yl)-2-{4-[(1-ethanimidoylpyrrolidin-3-yl)oxy]phenyl}propanoic Acid--hydrogen Chloride--water (1/1/5)
| Molecular Weight | 571.1 g/mol |
|---|---|
| Molecular Formula | C26H39ClN4O8 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 8 |
| Exact Mass | 570.2456419 g/mol |
| Monoisotopic Mass | 570.2456419 g/mol |
| Topological Polar Surface Area | 129 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 720 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 7 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)
ABOUT THIS PAGE
A 2-Naphthalenepropanoic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-Naphthalenepropanoic Acid, including repackagers and relabelers. The FDA regulates 2-Naphthalenepropanoic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-Naphthalenepropanoic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 2-Naphthalenepropanoic Acid supplier is an individual or a company that provides 2-Naphthalenepropanoic Acid active pharmaceutical ingredient (API) or 2-Naphthalenepropanoic Acid finished formulations upon request. The 2-Naphthalenepropanoic Acid suppliers may include 2-Naphthalenepropanoic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 2-Naphthalenepropanoic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 2-Naphthalenepropanoic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 2-Naphthalenepropanoic Acid active pharmaceutical ingredient (API) in detail. Different forms of 2-Naphthalenepropanoic Acid DMFs exist exist since differing nations have different regulations, such as 2-Naphthalenepropanoic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 2-Naphthalenepropanoic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 2-Naphthalenepropanoic Acid USDMF includes data on 2-Naphthalenepropanoic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 2-Naphthalenepropanoic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 2-Naphthalenepropanoic Acid suppliers with USDMF on PharmaCompass.
2-Naphthalenepropanoic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2-Naphthalenepropanoic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2-Naphthalenepropanoic Acid GMP manufacturer or 2-Naphthalenepropanoic Acid GMP API supplier for your needs.
A 2-Naphthalenepropanoic Acid CoA (Certificate of Analysis) is a formal document that attests to 2-Naphthalenepropanoic Acid's compliance with 2-Naphthalenepropanoic Acid specifications and serves as a tool for batch-level quality control.
2-Naphthalenepropanoic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 2-Naphthalenepropanoic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2-Naphthalenepropanoic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (2-Naphthalenepropanoic Acid EP), 2-Naphthalenepropanoic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2-Naphthalenepropanoic Acid USP).
LOOKING FOR A SUPPLIER?
